Retinal transcriptome analysis in db/db mice after sodium-glucose cotransporter 2 inhibitor application

被引：0
|
作者：
Ahn, Jeeyun [1 ,2 ]
Shin, Jooyoung [1 ,2 ]
Park, Junghyun [3 ]
Moon, Min Kyong [4 ,5 ]
机构：
[1] Seoul Natl Univ, Coll Med, Dept Ophthalmol, Seoul, South Korea
[2] Seoul Natl Univ, Seoul Metropolitan Govt, Boramae Med Ctr, Dept Ophthalmol, Seoul, South Korea
[3] Inje Univ, Seoul Paik Hosp, Dept Ophthalmol, Gimhae, South Korea
[4] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea
[5] Seoul Natl Univ, Seoul Metropolitan Govt, Boramae Med Ctr, Dept Internal Med, Seoul, South Korea
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2019年 / 60卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
5367
引用
收藏
页数：2
相关论文
共 50 条
  • [41] T-1095 -: Antidiabetic, sodium-glucose cotransporter inhibitor
    Doggrell, SA
    Castañer, J
    DRUGS OF THE FUTURE, 2001, 26 (08) : 750 - 753
  • [42] Sodium-Glucose Cotransporter 2 Inhibitors and Amputations
    Clements, Jennifer N.
    JAMA INTERNAL MEDICINE, 2019, 179 (03) : 451 - 452
  • [43] Sodium-glucose cotransporter 2 inhibitor-induced postoperative euglycaemic diabetic ketoacidosis after pancreatectomy
    Armstrong, Misha T.
    Murray-Ramcharan, Max
    Flory, James H.
    Jarnagin, William R.
    Wei, Alice C.
    BJS-BRITISH JOURNAL OF SURGERY, 2023, 110 (05): : 545 - 547
  • [44] Diabetic Ketoacidosis in a Patient with Type 2 Diabetes After Initiation of Sodium-Glucose Cotransporter 2 Inhibitor Treatment
    Storgaard, Heidi
    Bagger, Jonatan I.
    Knop, Filip K.
    Vilsboll, Tina
    Rungby, Jorgen
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2016, 118 (02) : 168 - 170
  • [45] Canagliflozin, an inhibitor of sodium-glucose cotransporter 2, for the treatment of type 2 diabetes mellitus
    Lamos, Elizabeth M.
    Younk, Lisa M.
    Davis, Stephen N.
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2013, 9 (06) : 763 - 775
  • [46] Dapagliflozin: A new sodium-glucose cotransporter 2 inhibitor for treatment of type 2 diabetes
    Vivian, Eva M.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2015, 72 (05) : 361 - 372
  • [47] Empagliflozin, a sodium-glucose cotransporter 2 inhibitor, suppresses the progression of atherosclerosis in diabetic apoE-deficient mice
    Murakami, Saiko
    Matsumura, Takeshi
    Senokuchi, Takafumi
    Ishii, Norio
    Fukuda, Kazuki
    Yamada, Sarie
    Morita, Yutaro
    Nishida, Shuhei
    Sato, Miki
    Motoshima, Hiroyuki
    Kondo, Tatsuya
    Araki, Eiichi
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2016, 120 : S99 - S99
  • [48] Sodium-glucose cotransporter 2 inhibitor dapagliflozin attenuates protein abundance of collectin kidney 1 in diabetic mice
    Jensen, Mia
    Enggaard, Camilla
    Andresen, Jesper K.
    Paralasah, Yaseelan
    Hansen, Soren W. K.
    Svenningsen, Per
    Jensen, Boye L.
    ACTA PHYSIOLOGICA, 2023, 239
  • [49] The sodium-glucose cotransporter 2 inhibitor tofogliflozin prevents diabetic kidney disease progression in type 2 diabetic mice
    Li, Zi
    Murakoshi, Maki
    Ichikawa, Saki
    Koshida, Takeo
    Adachi, Eri
    Suzuki, Chigure
    Ueda, Seiji
    Gohda, Tomohito
    Suzuki, Yusuke
    FEBS OPEN BIO, 2020, 10 (12): : 2761 - 2770
  • [50] EFFECTS OF SODIUM-GLUCOSE COTRANSPORTER 2 INHIBITOR, CANAGLIFLOZIN ON GLOMERULAR HYPERFILTRATION AND OXIDATIVE STRESS IN MICE WITH TYPE 2 DIABETES
    Kondo, Megumi
    Kidokoro, Kengo
    Wada, Yoshihisa
    Tokuyama, Atsuyuki
    Kadoya, Hiroyuki
    Sasaki, Tamaki
    Kashihara, Naoki
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, 35 : 26 - 26
12345